SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: peter michaelson who wrote (2204)8/9/1998 9:40:00 PM
From: Mike Moran  Read Replies (1) of 2911
 
Peter...

The Banyan deal offered Medix a total of $7 million cash and $2 million stock. For the sake of this discussion, let's say that the $2 million in stock was/is valueless. That would leave, assuming the Banyan deal were still viable (if it ever was), about $7 million cash for what amounts to about $26 million in revenue and $1.7 million EBITDA.

I looked the other day, because I know nothing about the sale value of service businesses, and found some stuff in a 1997 Merrill-Lynch report that stated that licenced medical service businesses sell for between 2.5 times and 4 times EBITDA. I would guess the Medix businesses are licensed.

Still valuing the Banyan deal only for its cash, I see that Banyan offered the very top end of the scale, and then threw in the stock on top of it. Guess that's a reason why it didn't happen.

However, using that same formula, and assuming there isn't a deep dark secret at Medix that accounted for the Banyan deal blowing up, a sale of assets in the middle of the scale will yield about $5-$5.5 million in a cash deal. Even accounting for liabilities, that's still north of $.25/share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext